iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large increase in short interest in April. As of April 15th, there was short interest totaling 2,307 shares, an increase of 618.7% from the March 31st total of 321 shares. Approximately 1.5% of the shares of the company are sold short. Based on an average daily trading volume, of 3,193 shares, the short-interest ratio is currently 0.7 days.

iShares Neuroscience and Healthcare ETF Stock Down 0.5%

Shares of IBRN traded down $0.16 on Friday, reaching $34.48. The stock had a trading volume of 1,477 shares, compared to its average volume of 1,974. The firm has a market capitalization of $5.17 million, a PE ratio of 15.61 and a beta of 0.82. The firm has a 50-day moving average of $32.56 and a 200 day moving average of $31.53. iShares Neuroscience and Healthcare ETF has a twelve month low of $21.11 and a twelve month high of $37.00.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.